Jump to content

MVP - MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED


ShareCafe
 Share

Recommended Posts

and it has been downhill for the last few years.... $5.00 at start of 2022 down to $1.40 in June and a bit of a retrace to $2.40 recently.... and now a Trading Halt and Cap Raise.

Still running with Penthrox (Green Whistle) and Repiratory (Asthma).
Sales increasing, still EBIT negative.

Raising $30 million at $2.00 a share
• A fully underwritten capital raising of approximately $30 million comprising:
• An institutional placement of New Shares to eligible investors to raise approximately $15.0 million
• A 1 for 9.5 pro rata accelerated non renounceable entitlement issue for approx $15 million

Going towards

  • Operating activities, including growth in Europe and Australia and enhanced organisational capability
  • Capex operations
Link to comment
Share on other sites

  • Replies 31
  • Created
  • Last Reply

Top Posters In This Topic

Top Posters In This Topic

Posted Images

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
 Share


×
×
  • Create New...